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Abstract
 
Lymph node (LN) function depends on T and B cell compartmentalization, antigen presenting
cells, and high endothelial venules (HEVs) expressing mucosal addressin cell adhesion molecule
(MAdCAM-1) and peripheral node addressin (PNAd), ligands for naive cell entrance into LNs.
Luminal PNAd expression requires a HEV-restricted sulfotransferase (HEC-6ST). To investi-
gate LT
 
  
 
’s activities in lymphoid organogenesis, mice simultaneously expressing LT
 
 
 
 and
LT
 
 
 
 under rat insulin promoter II (RIP) control were compared with RIPLT
 
 
 
 mice in a
model of lymphoid neogenesis and with LT
 
 
 
 
 
/
 
 
 
 mice. RIPLT
 
  
 
 pancreata exhibited massive
intra-islet mononuclear infiltrates that differed from the more sparse peri-islet cell accumula-
tions in RIPLT
 
 
 
 pancreata: separation into T and B cell areas was more distinct with promi-
nent FDC networks, expression of lymphoid chemokines (CCL21, CCL19, and CXCL13)
was more intense, and L-selectin
 
 
 
 cells were more frequent. In contrast to the predominant ab-
luminal PNAd pattern of HEV in LT
 
 
 
 
 
/
 
 
 
 MLN and RIPLT
 
 
 
 pancreatic infiltrates, PNAd was
expressed at the luminal and abluminal aspects of HEV in wild-type LN and in RIPLT
 
  
 
 pan-
creata, coincident with HEC-6ST. These data highlight distinct roles of LT
 
 
 
 and LT
 
  
 
 in
lymphoid organogenesis supporting the notion that HEC-6ST–dependent luminal PNAd is
under regulation by LT
 
  
 
.
 
Key words: lymphoid organogenesis • chemokines • sulfotransferase • inﬂammation • 
high endothelial venules
 
Introduction
 
Members of the TNF/lymphotoxin (LT)
 
*
 
 ligand-receptor
families and lymphoid chemokines play critical roles in LN
development. The design of LNs serves adaptive immunity
by facilitating interactions between antigen-presenting cells
and responsive lymphocytes. Thus, LN function depends
on the presence of naive, L-selectin
 
 
 
 lymphocytes, distinct
T and B cell compartments, antigen presenting cells, stro-
mal cells, and specialized blood vessels called high endothe-
lial venules (HEVs). The cells of HEV express peripheral
node addressin (PNAd) and mucosal addressin cell adhesion
molecule (MAdCAM-1), adhesion molecules that serve as
ligands for L-selectin and 
 
 
 
4
 
 
 
7
 
, respectively, expressed by
blood-borne T and B cells required for their extravasation
into LNs (1).
During early development, HEVs of all LNs express
MAdCAM-1, but soon after birth peripheral LN-HEVs
(PLN-HEVs) switch to PNAd, whereas mesenteric LN-
HEVs (MLN-HEVs) continue to express MAdCAM-1 in
addition to PNAd (2). PNAd, an L-selectin ligand, de-
tected by the prototypic antibody MECA 79 (3, 4), is a
sulfo sialyl-Lewis
 
x 
 
determinant common to a defined set of
glycoproteins (GlyCAM-1, CD34, podocalyxin, or MAd-
CAM-1; reference 5). A HEV-specific sulfotransferase, ab-
breviated here as HEC-6ST, that mediates the sulfation at
the C6-position of GlcNAc residues of these glycoproteins
was described by two groups (6, 7). This enzyme is neces-
sary for luminal expression of PNAd, as LNs of HEC-6ST–
deficient mice lack apical, luminal PNAd expression (8).
However, PLN- and MLN-HEV of HEC-6ST–deficient
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Abbreviations used in this paper:
 
 HEC-6ST, high endothelial cell sul-
fotransferase; HEV, high endothelial venule; LT, lymphotoxin; MAd-
CAM-1, mucosal addressin cell adhesion molecule; MLN, mesenteric
lymph node; PLN, peripheral lymph node; PNAd, peripheral node ad-
dressin; PP, Peyer’s patch; RIP, rat insulin promoter.T
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mice retain basal, abluminal PNAd expression, a pattern
similar to that seen in Peyer’s patches (PP). HEC-6ST–
deficient mice also exhibit a dramatic reduction in LN cell
number consistent with the view that luminal PNAd ex-
pression has an important role in LN cell recruitment (8).
The requirement of HEC-6ST for luminal PNAd expres-
sion and its importance in cell recruitment to LNs indicates
a crucial role for this enzyme in LN development. Up-
stream factors that regulate HEC-6ST expression remain to
be elucidated. We have previously suggested that the
LT
 
  
 
 complex may be involved (9).
Several lines of evidence demonstrate that LT
 
  
 
and
LT
 
  
 
 play crucial, nonredundant roles in lymphoid organ
development. Mice deficient in LT
 
 
 
, a homotrimeric solu-
ble factor that binds to the two TNF receptors, TNFRI
and TNFRII (10), lack all LNs and PP, and have highly
disorganized spleens (11, 12). Furthermore, transgenic ex-
pression of LT
 
 
 
 under the control of the rat insulin gene
promoter element (RIPLT
 
 
 
) partially restores lymphoid
organs and function to LT
 
 
 
 
 
/
 
 
 
 mice (13). LT
 
 
 
, a mem-
brane-bound protein, on its own is nonfunctional, but can
form heterotrimeric complexes with LT
 
 
 
 (10, 14). While
LT
 
 
 
2
 
 
 
1
 
 can bind TNFRI and TNFRII, its signaling capac-
ity through these receptors has not yet been elucidated.
LT
 
 
 
1
 
 
 
2
 
 signals through another member of the TNF re-
ceptor family, LT
 
 
 
R (15, 16). LT
 
 
 
 
 
/
 
 
 
 mice lack all PLNs
and PP, but retain MLNs and cervical LNs, and their
splenic defects are less pronounced than those of LT
 
 
 
 
 
/
 
 
 
mice (17, 18). In addition, treatment of pregnant mice with
LT
 
 
 
R-Ig fusion protein results in progeny that lack most
PLNs, but retain MLNs (19).
Chemokines characteristic of LNs include CCL19
(EBV-induced molecule 1 ligand chemokine [ELC]) and
CCL21 (secondary lymphoid chemokine [SLC]) that are
constitutively expressed by T cell zone stromal cells (20).
CCL21 mRNA is also expressed by HEVs in PP and LNs
(21, 22). In addition, CXCL13 (B lymphocyte chemoat-
tractant [BLC]) is constitutively expressed by stromal cells
in B cell follicles (23). As the spleens of LT
 
 
 
 
 
/
 
 
 
 and LT
 
 
 
 
 
/
 
 
 
mice exhibit a dramatic reduction in lymphoid chemokines
(24), LT-regulated expression of these chemokines is one
likely key mechanism in lymphoid organ development.
Transgenic mice that express TNF/LT ligands or either
of the above mentioned lymphoid chemokines under RIP
control develop cellular accumulations with characteristics
of lymphoid organs at the sites of transgene expression (25–
31). This ectopic lymphoid tissue, organized through a pro-
cess called lymphoid neogenesis, contains elements of both
chronic inflammation and lymphoid organs and has been
observed in several autoimmune diseases (32). Interestingly,
in some cases, these cellular accumulations are vascularized
with endothelia showing morphologic characteristics of
HEV expressing PNAd and MAdCAM-1. For example,
RIPLT
 
 
 
 mice show HEV-like vessels within pancreatic in-
filtrates that express MAdCAM-1 and low levels of PNAd
(27, 33). These cellular accumulations are reminiscent of a
developing LN, and are predominantly mediated by LT
 
 
 
3
 
through TNFRI (34). In these RIPLT
 
 
 
 mice LT
 
 
 
, most
 
likely in the form of LT
 
  
 
 expressed by infiltrating lym-
phocytes, is implicated in PNAd expression since the infil-
trates of RIPLT
 
 
 
.LT
 
 
 
 
 
/
 
 
 
 mice lack PNAd reactivity and
exhibit a reduction in L-selectin
 
 
 
 cells, although MAd-
CAM-1 expression remains prominent (33). Furthermore,
LT
 
 
 
3
 
 treatment can induce MAdCAM-1 in an endothelial
cell line in vitro (35). These data are consistent with the
previously articulated hypothesis that LT
 
 
 
 alone suffices for
MAdCAM-1 expression and MLN organogenesis but
LT
 
  
 
 is necessary for PLN development and their popula-
tion by L-selectin
 
 
 
 cells through regulation of PNAd (9).
The mechanisms by which LT
 
  
 
 regulates PNAd expres-
sion have not been elucidated. Here we investigated the
contributions of LT
 
 
 
 and LT
 
  
 
 to the process of lymphoid
neogenesis with particular attention to the HEV phenotype
in mice simultaneously transgenic for LT
 
 
 
 and LT
 
 
 
, each
under RIP control and in LT
 
 
 
 
 
/
 
 
 
 MLN. Coexpression of
LT
 
 
 
 and LT
 
 
 
 in the pancreas resulted in invasive, intra-islet
cellular accumulations that differed both qualitatively and
quantitatively from those seen in RIPLT
 
 
 
 transgenics: sep-
aration into T–B cell areas was more distinct, expression of
lymphoid chemokines was more intense, and L-selectin
 
 
 
cells made up a much higher proportion of the mononu-
clear infiltrate. Most notably, PNAd expression in HEV
was prominent in luminal locations. With a recently devel-
oped antibody, we showed that expression of HEC-6ST
depended on coexpression of LT
 
 
 
 and LT
 
 
 
, and correlated
with luminal expression of PNAd in HEV.
 
Materials and Methods
 
Mice.
 
To generate the RIPLT
 
 
 
 transgene construct, the rat
insulin promoter II was recloned in Bluescript SK
 
 
 
 (RIP-BSK)
from a RIP-TNF
 
 
 
 construct provided by Dr. Allison Greene
(Section of Immunobiology, Yale University School of Medi-
cine, New Haven, CT). A genomic mouse LT
 
 
 
 DNA fragment
was generated by anchored PCR using a genomic clone PNN03/
PL001 provided by Dr. Jeffery Browning (Biogen, Cambridge,
MA) as template, introducing an NheI cloning site and Kozak
consensus sequence upstream of the initiation codon and a Hind-
III site downstream of the polyadenylation sequence. This frag-
ment was inserted in RIP-BSK downstream of RIP, and re-
cloned. The RIPLT
 
 
 
 fragment was excised from a preparative
gel, purified according to standard protocol to apparent homoge-
neity and confirmed by resequencing. RIPLT
 
 
 
 DNA was in-
jected into SJLBL/6 F2 oocytes by the Yale Animal Resource
Center Transgenics Mouse Facility as described previously (26).
Positive founders were identified by PCR and Southern blot
analysis of tail DNA using a 
 
32
 
P-labeled mouse LT
 
 
 
 probe pre-
pared by random-primer labeling (Amersham Biosciences).
Mice transgenic for RIPLT
 
 
 
 have been described previously
(26, 27). These mice were bred to RIPLT
 
 
 
 transgenic mice.
Progeny that were heterozygous for both transgenes were used
for further study. C57BL/6 mice were purchased from the Na-
tional Cancer Institute of the National Institutes of Health. LT
 
 
 
-
deficient mice have been described previously (18). All mice
were studied under a protocol approved by the Yale University
Institutional Animal Care and Use Committee.
 
Preparation of HEC-6ST Antibody.
 
Polyclonal rabbit anti-sera
specific for mouse sulfotransferase was generated by immunizationT
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with three different peptides derived from mouse HEC-6ST. Pep-
tides were specifically chosen for sequences lacking similarity to
previously described murine sulfotransferases (36). The peptides
were: (a) CHMSVHRHLSQREESRR-COOH; (b) KIICK-
SQVDIVKAIQTLPE-COOH; (c) RGKGMGQHAFHTNC-
COOH. Peptides were synthesized at the W.M. Keck Foundation
facility at Yale University and included a cysteine residue for con-
jugation to keyhole limpet hemocyanin (KLH; Calbiochem).
Peptide-KLH conjugation was performed using the chemical
cross-linker SPDP (Pierce Chemical Co.) according to manufac-
turers’ instructions. Pooled peptide–KLH conjugates (2 mg/ml)
were mixed with TiterMax Gold (CytRx Corporation) in a 1:1
ratio and injected subcutaneously into New Zealand white rabbits.
After the third boost, the serum was found to specifically stain
HEV in sections of PLNs, and the binding was inhibited by incu-
bation with “peptide c” (unpublished data). The antiserum was
then purified by affinity chromatography using “peptide c” as sor-
bent, and tested in indirect immunofluorescence.
 
Histologic Analysis.
 
Standard hematoxylin and eosin staining
procedures were used on formalin fixed, paraffin embedded tissue
for histological analysis. Slide preparation and staining was per-
formed by the Dermatopathology Laboratory at the Yale Univer-
sity School of Medicine.
For immunohistochemistry, pancreas and kidney tissue were
dissected and immediately frozen in OCT compound (Tissue-
Tek) on dry ice. Sections of 7 
 
 
 
m were cut onto poly-
 
l
 
-lysine–
coated glass slides (Sigma Diagnostics), fixed in 100% cold ace-
tone for 10 min and stored at 
 
 
 
70
 
 
 
C. For staining, slides were
air-dried at room temperature and blocked in 0.5% TNB (NEN
Life Science Products) in TRIS-HCl for 45 min, followed by in-
cubation in 1% mouse serum in PBS containing 0.1M Tris/0.1%
Tween 20 (blocking solution) for 30 min. Sections were stained
in a humidified tray with 2 
 
 
 
g/ml of anti-B220, anti-CD4, anti-
CD8, anti-CD35 (CR1), anti-PNAd (MECA 79), and anti–
MAdCAM-1 (MECA 367) primary antibodies diluted in block-
ing solution. Biotinylated species-specific secondary antibodies
were diluted 1:250 in blocking solution and incubated on sec-
tions for 30 min. All antibodies were obtained from BD Bio-
sciences. Slides were treated with streptavidin-conjugated alkaline
phosphatase VectaStain reagent (Vector Laboratories), according
to the manufacturer’s protocol (Vector Laboratories). Enzyme re-
activity was detected using Vector Red (Vector Laboratories)
containing 100 mM levamisole to inhibit endogenous alkaline
phosphatase activity. In all experiments, species-specific isotype-
matched irrelevant antibody was used as a control. Sections were
counterstained, as needed, with 0.05% methyl green (Sigma-
Aldrich) and mounted in Crystal/Mount (Biomeda).
For immunofluorescence, PLN and pancreas tissue were iso-
lated and slides prepared as above. Sections were blocked with 5%
mouse serum/3% BSA in PBS, pH 7.4. Purified rabbit anti-HEC-
6ST antibody was diluted 1:1,000 in blocking solution, and
MECA 79 antibody (BD Biosciences) was used at 2 
 
 
 
g/ml. Anti-
HEC-6ST and MECA 79 primary antibodies were incubated on
slides for 1 h at ambient temperature. For HEC-6ST detection,
sections were incubated with biotinylated goat anti–rabbit IgG
(Jackson ImmunoResearch Laboratories) followed by incubation
with Cy2-conjugated streptavidin (Jackson ImmunoResearch Lab-
oratories). MECA 79 was detected by incubation with Cy3-conju-
gated goat anti-Rat IgM antibody (Jackson ImmunoResearch
Laboratories). Sections were counterstained with 20% Harris’ he-
matoxylin (Sigma Diagnostics) and mounted with Fluorosave (Cal-
biochem). Slides were analyzed by fluorescence microscopy using a
Carl Zeiss Microimaging, Inc. Axioskop microscope.
 
In Situ Hybridization.
 
The technique previously described by
Hjelmstrom et al. (37) was used. Briefly, pancreas and kidney
were isolated and fixed in 4% paraformaldehyde/0.14 M Soren-
son’s phosphate buffer overnight followed by 30% sucrose/4%
paraformaldehyde in 0.14 M Sorenson’s phosphate buffer. Tissue
was frozen in OCT compound (Tissue-Tek) on dry ice and sec-
tions of 7 
 
 
 
m were cut onto poly-
 
l
 
-lysine coated slides. Sections
were washed in PBS, prehybridized for 1–2 h, and hybridized
overnight at 54
 
 
 
C with sense or antisense digoxigenin (DIG)-
labeled riboprobes in hybridization solution. Sections were sub-
jected to high stringency washes followed by overnight in-
cubation with alkaline phosphatase–conjugated sheep anti-DIG
antibody (Roche) and developed with nitroblue tetrazolium/
5-bromo-4-chloro-3-indolyl phosphate (NBT/BCIP; Boehringer).
Signal development was stopped by washing slides in 10 mM
Tris/1 mM EDTA, pH 8.0. Sections were counterstained with
0.05% methyl green and mounted in Crystal Mount (Biomeda).
Riboprobes used for in situ hybridization included: LT
 
 
 
, LT
 
 
 
,
CCL21, CCL19, and CXCL13 sense and antisense probes (37,
38). CCL19 cDNA was a generous gift from Dr. Jason Cyster,
University of California, San Francisco, San Francisco, CA. All
DIG-labeled probes were prepared as described previously (37).
In all experiments, sense probes were used as negative controls.
 
Preparation of Lymphocytes.
 
PLN and pancreas tissue were har-
vested from mice after intracardial perfusion with HBSS (GIBCO
BRL). PLN was homogenized in HBSS and passed over a 40 
 
 
 
m
cell strainer (Becton Dickinson). Pancreatic infiltrates were pre-
pared by digestion of pancreas in RPMI 1640 (GIBCO BRL)
supplemented with penicillin/streptomycin, 0.01% DNase I
(Roche), and 0.15% Collagenase P (Roche). Tissue was incu-
bated for 15 min in a 37
 
 
 
C shaking waterbath. Collagenase diges-
tion was stopped by washing cells with excess cold HBSS. Di-
gested tissue was passed over a 40 
 
 
 
m cell strainer to isolate
pancreatic-infiltrating cells. Isolated cells, from all tissues, were
resuspended in HBSS and quantitated using a hemacytometer.
 
Flow Cytometric Analysis.
 
FACS
 
® staining was performed by
conventional staining procedures using either FITC- or PE-
conjugated anti-CD4, anti-CD8, anti-B220, anti-CD11c, anti-
CD11b, and anti-CD62L antibodies (all from BD Biosciences).
Data were collected on a Becton Dickinson FACScan™ flow cy-
tometer and analyzed with FlowJo software.
Results
Generation of RIPLT  Transgenic Mice. The RIPLT 
transgenic construct was designed with the rat insulin pro-
moter II (RIP) driving expression of murine LT . South-
ern blot analysis and PCR identified 14 transgene positive
mice of 62 mice (unpublished data). Germline transmission
was confirmed in F1 crosses of RIPLT  transgenic mice to
C57BL/6 mice. By in situ hybridization with a DIG-
labeled LT  anti-sense riboprobe, LT  transgene transcrip-
tion was apparent in the islets of Langerhans, presumably in
the insulin-producing   cells (Fig. 1 A). Low LT  mRNA
was also apparent in the kidney in proximal convoluted tu-
bules (Fig. 1 B) in a pattern similar to the LT  expression
associated with the promoter in the RIPLT  kidney (27).
Two lines of transgenic mice were selected for further
study: line 9311 carries approximately two copies and line
9327 carries 20 copies of the transgene. These lines were
crossed to RIPLT  mice to generate RIPLT   mice.T
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Comparable results were obtained with the progeny of the
two lines.
Extensive Intra-islet Invasion by Cellular Infiltrates in RIP-
LT   Pancreata. RIPLT , RIPLT , and RIPLT  
pancreata were analyzed by in situ hybridization with LT 
and LT  antisense riboprobes, and tissue sections were
counterstained with methyl green to evaluate leukocytic
infiltration. When examined at 5–7 wk of age, high levels
of LT  mRNA accumulation were found in RIPLT 
pancreata (Fig. 1 C). In addition, a very low signal for LT 
was seen within the cellular infiltrate associated with the is-
lets, most likely resulting from transcriptional activity of
infiltrating T and B cells (unpublished data). As noted
above, RIPLT  pancreata revealed LT  mRNA, but no
LT  mRNA. In RIPLT   mice, both LT  and LT 
were transcribed selectively in the islets (Fig. 1, D–F). A
peri-islet leukocyte accumulation in the periductal areas of
the pancreas just outside the islet developed in  40% of
the islets in RIPLT  mice, confirming previous reports
(Fig. 2 B; reference 34). Consistent with the fact that LT 
in the absence of LT  does not form a functional ligand,
no alterations were seen in any tissue investigated in
RIPLT  mice (Fig. 2 C). However, RIPLT   mice,
when examined as early as 5 wk of age, exhibited extensive
mononuclear cell infiltrates in the pancreas at the sites of
transgene expression (Fig. 2 D). Fig. 1 F shows multiple
LT   positive islets encompassed and invaded by cellular
infiltrates. Unlike the peri-islet infiltrate observed in
RIPLT  pancreata (Fig. 2 B), the cellular accumulations in
RIPLT   pancreata massively invaded the islet distorting
normal architecture (Figs. 1 F and 2 D). Moreover,  90%
of the islets in RIPLT   pancreata showed at least some
pathology. The extent of individual islet involvement
within the same pancreas ranged from almost total obliter-
ation to a relatively intact islet as shown in Fig. 1 F. In ev-
ery RIPLT   pancreas evaluated at least some   cells re-
mained, as detected by transgene transcription (Fig. 1, D–F)
and insulin staining (unpublished data). Consistent with
the much higher level of cellular accumulation,  10 times
more mononuclear cells (4.5   106 cells at 5 wk of age)
were recovered from individual RIPLT   pancreata than
from RIPLT  pancreata.
Figure 1. LT expression in RIPLT  and RIPLT  
mice. In situ hybridization for RIPLT  transgene tran-
scription with a DIG-labeled antisense LT  riboprobe
on RIPLT  pancreas (A) and kidney (B). In situ hy-
bridization with DIG-labeled LT  (C and D) and LT 
(E and F) antisense riboprobes on RIPLT  (C) and
RIPLT   (D–F) pancreas. E is a higher magnification
of F showing the extensive cellular accumulation in
RIPLT   pancreatic tissue. Objective 40  (A–E); ob-
jective 5  (F).T
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The Cellular Phenotypes and Compartmentalization of RIP-
LT   Infiltrates Are Similar to a Lymph Node. To com-
pare the cellular composition of pancreatic infiltrates of
RIPLT   mice with those of RIPLT  mice, we per-
formed immunohistochemistry and FACS® analyses of infil-
trating cells recovered from RIPLT   and RIPLT  pan-
creata. The cellular composition of RIPLT   infiltrates was
highly similar to that of PLNs; all cell populations of a typi-
cal PLN were represented, although there was a higher pro-
portion of CD11c  cells and a lower proportion of B220 
cells (Table I). Immunohistochemistry of serial tissue sec-
tions reacted with anti-B220, -CD4, and -CD8 and -CR1
antibodies (Fig. 3) revealed a distinct delineation between B
and T cell compartments and the presence of follicular den-
dritic cells in B cell areas of RIPLT   infiltrates, indicating
a cellular compartmentalization characteristic of secondary
lymphoid tissue. One hallmark of PLNs is a high proportion
of L-selectin  cells. L-selectin is expressed on white blood
cells, including naive T and B lymphocytes, and is essential
for cell recruitment into the PLN. The relative number of
L-selectin  cells in RIPLT  pancreata ranged from 28% in
young mice to 55% in 1-yr-old mice (n   6) similar to pre-
vious reports of L-selectin expression in RIPLT  kidney
(33). In contrast, RIPLT   pancreatic infiltrates contained
79% L-selectin  cells as early as 7 wk of age, much more
comparable to the 85% L-selectin  cells in PLN of C57BL/
6 mice (Table I) supporting the hypothesis that LT   con-
tributes to the recruitment of L-selectin  cells.
Transcription of Lymphoid Chemokines in RIPLT   Pancre-
atic Infiltrates. To gain insight into the mechanisms driv-
ing the cell compartmentalization in RIPLT   pancreatic
infiltrates, we investigated chemokine expression by in
situ hybridization analysis. Previous studies have shown
CCL21 and CXCL13 lymphoid chemokine mRNA in
RIPLT  kidney infiltrates (37). The more striking T and
B cell compartmentalization in RIPLT   pancreatic infil-
trates suggested a further investigation of CCL21, CCL19,
and CXCL13. All three lymphoid chemokine transcripts
were substantially more intense and extensive in RIPL-
T   than in the previously reported RIPLT  pancreata
(Fig. 4). This is particularly striking in the case of CCL21
and CCL19. CCL21 mRNA was detected in HEV-like
structures within RIPLT   infiltrates (Fig. 4 B, inset).
CCL19 transcripts were localized in the infiltrate in a retic-
ular pattern similar to that observed in C57BL/6 PLN
(Fig. 4, C and D). It was notable that CCL19 was also ex-
pressed within the remaining islet tissue, likely by islet in-
Figure 2. Histologic comparison of C57BL/6 and
RIPLT pancreata. Hematoxylin and eosin stain of pancreas
of C57BL/6 (A), RIPLT  (B), RIPLT  (C), and RIPLT  
(D) mice. RIPLT  pancreas is indistinguishable from that
of nontransgenic mice. RIPLT  exhibit a peri-islet cellular
accumulation in contrast to the extensive invasive intra-
islet cellular accumulation observed in RIPLT   mice.
Objective 20 .
Table I. Cellular Composition of RIPLT   Infiltrates
Source of cells
C57BL/6 PLN RIPLT   pancreas
Cell type
CD4  45.5 44.9
CD8  20.0 15.3
B220  36.1 17.1
CD11b  8.9 5.3
CD11c  4.2 9.6
L-selectin  85.3 79.2
Leukocytes were isolated from C57BL/6 PLN and RIPLT  
pancreata. Cells were stained with FITC- or PE-conjugated antibodies
specific for B220, CD4, CD8, CD11c, CD11b, and L-selectin as
described in the Materials and Methods. The percentage of positive cells
was determined by flow cytometry.T
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filtrating dendritic cells. High expression of CCL21 and
CCL19 correlated with the high number of T cells and
dendritic cells observed in RIPLT   infiltrates. CXCL13
mRNA was detected at relatively low levels within the in-
filtrates (Fig. 4 F), consistent with the lower proportion of
B cells (Table I). Even so, CXCL13 mRNA localized to
regions distinct from those in which CCL19 and CCL21
were found, consistent with the organization of RIPLT  
infiltrates into separate B and T cell compartments. No
mRNA of CCL21, CCL19, and CXCL13 was detected by
in situ hybridization studies of C57BL/6 and RIPLT 
pancreas (unpublished data).
LT   Regulates Luminal PNAd Expression. Previous
studies of the RIPLT  mouse had revealed MAdCAM-1
and abluminal PNAd expression on HEV-like vessels at the
sites of transgene expression (27, 33; Fig. 5, C and D). In
Figure 3. Cellular compartmentalization of RIPLT   infiltrates. RIPLT   pancreatic tissue were analyzed by immunohistochemistry to detect B
cells, T cells, and FDCs within RIPLT   infiltrates. Serial sections (A–C) were stained with anti-B220 (A), anti-CD4 (B), and anti-CD8 (C). Serial sec-
tions (D and E) were stained with anti-B220 (D) and anti-CR1 (E). All were visualized with Vector Red substrate. Objective 40  (A–C); objective 20 
(D and E). I, Islet tissue detected by anti-insulin staining (not shown).
Figure 4. In situ hybridization
analysis of lymphoid chemokine
transcription in LN and RIPLT  
pancreas. C57BL/6 PLN (A, C,
and E) and serial sections of
RIPLT   pancreas (B, D, and
F) were probed with DIG-
labeled antisense CCL21 (A and
B), CCL19 (C and D), and
CXCL13 (E and F) riboprobes.
Positive signal is seen as dark
purple staining. Arrows in A and
B denote high magnification in-
set. I, Islet.T
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the RIPLT   pancreas immunohistochemistry with
MECA 367 antibody also revealed high levels of MAd-
CAM-1 within and around the infiltrates of the islet (un-
published data). Furthermore, consistent with the high
number of L-selectin  cells (Table I), there was intense lu-
minal MECA 79 staining in RIPLT   pancreata with a
few vessels displaying only abluminal MECA 79 (Fig. 5, E
and F) as determined by immunohistochemistry. This is in
contrast to the predominately abluminal MECA 79 pattern
in the RIPLT  pancreas (Fig. 5, C and D; reference 33).
This pericellular (i.e., luminal and abluminal) MECA 79
staining pattern in RIPLT   infiltrates was clearly different
from that of RIPLT  pancreata and highly reminiscent of a
mature LN (Fig. 5, A and B). In addition, RIPLT   pan-
creatic infiltrates exhibited an increase in the number of
MECA 79  vessels when compared with RIPLT  infil-
trates. To further investigate a role for LT  in luminal
PNAd expression, immunohistochemistry with MECA 79
was performed on LT  /  MLNs. In contrast to the peri-
cellular MECA 79 staining pattern on almost all wild-type
LN–HEV (Fig. 5, A and B), abluminal MECA 79 staining
was seen on many LT  /  MLN–HEV and there was a
corresponding 20% reduction in L-selectin  cells in the
MLN (Fig. 5, G and H, and unpublished data).
LT   Regulates Luminal PNAd through Induction of HEC-
6ST. Given the luminal PNAd expression and high con-
tent of L-selectin  cells observed in RIPLT   pancreatic
infiltrates and the reduction in luminal PNAd staining in
LT  /  MLNs, we investigated the potential mechanisms
by which LT   could influence expression of luminal
PNAd. We focused on expression of HEC-6ST, a key en-
zyme of the PNAd-generating biosynthetic pathway that
previous studies have shown to be selectively transcribed in
LN HEVs (6, 7) and to regulate luminal PNAd expression
(8). Using a recently developed antibody to HEC-6ST, we
evaluated its expression in HEVs of C57BL/6 PLNs, LT  / 
MLNs, and in the infiltrates of RIPLT  and RIPLT  
pancreata. Double staining of C57BL/6 PLN-HEVs with
anti-HEC-6ST and MECA 79 revealed concomitant lumi-
nal PNAd and HEC-6ST expression (Fig. 6). The inset in
Fig. 6 shows that MECA 79 staining was confined to the
cell surface, whereas HEC-6ST was expressed intracellu-
larly, consistent with its expected location in the Golgi appa-
ratus (39). HEC-6ST expression was reduced in LT  / 
MLN HEVs, particularly when abluminally stained vessels
were evaluated (Fig. 6). However, we noted that luminal
MECA 79 staining could be found on some HEV of LT  / 
(Fig. 5, G and H). Interestingly, HEC-6ST staining was also
positive in those latter vessels (unpublished data). HEC-6ST
expression was apparent in MECA 79  vessels of RIPLT  
infiltrates but not detected in RIPLT  pancreatic infiltrates
(Fig. 7), consistent with the increase in luminal PNAd ex-
pression in the former (Figs. 5 and 7). Nevertheless, even
in RIPLT   infiltrates, there were still some abluminally
stained vessels that were negative for HEC-6ST.
Discussion
The cell infiltrates recruited by ectopic LT  and LT  
expression and their organized tissue architecture share
many characteristics with LN structure and chronic inflam-
matory foci in autoimmune diseases. The present study
elucidates a key mechanism in lymphoid neogenesis (i.e.,
generation of the vascular signals directing recruitment of
the appropriate cells to the site of transgene expression) and
thus by extrapolation is key to understanding LN develop-
Figure 5. LT   contributes to luminal PNAd expression on HEV. PNAd expression was detected by immunohistochemistry analysis with MECA 79
antibody in C57BL/6 PLN (A and B), RIPLT  pancreas (C and D), RIPLT   pancreas (E and F), and LT  /  MLN (G and H). LT  /  MLN exhib-
ited a reduction in luminal MECA 79 expression. RIPLT   pancreata exhibited an increase in the number of MECA 79  vessels and in luminal PNAd
expression compared with the predominately abluminal pattern observed in RIPLT  pancreatic infiltrates. Objective 20  (A, C, E, and G); objective
40  (B, D, F, and H).T
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ment and inflammatory disease processes. A mechanism for
LT  in lymphoid neogenesis, particularly in the induction
of MAdCAM-1 expression on endothelial cells, had been
established in RIPLT  transgenic mice (26, 27, 33, 34) and
by in vitro endothelial cell treatment with this cytokine
(35). Although LT  had been implicated in the generation
of the MECA 79 epitope, the mechanism underlying
PNAd regulation remained unknown (33). The crucial role
of LT , in the form of the LT   complex, which is re-
vealed here by its coincident expression with HEC-6ST,
points to a mechanism of HEV differentiation in LNs and
in chronic inflammation.
The RIPLT   mouse presents a unique opportunity to
evaluate the complementary roles of LT  and LT   in
lymphoid neogenesis. The quantitative and qualitative dif-
ferences in the lymphoid accumulations, chemokine expres-
Figure 6. LT  –induced luminal PNAd correlates with HEC-6ST expression. Fixed tissue sections of C57BL/6 PLN (top panel) and LT  /  MLN
(bottom panel) were analyzed by two-color immunofluorescence staining with MECA 79 (red) and anti-HEC-6ST (green) antibodies. C57BL/6 PLN
exhibited pericellular PNAd expression with concomitant HEC-6ST expression in HEV. Top panel inset of C57BL/6 PLN-HEV demonstrates intra-
cellular HEC-6ST expression and cell surface PNAd expression. Two-color analysis of LT  /  MLN, with particular attention to vessels that show only
abluminal MECA 79  staining, reveals the absence of HEC-6ST expression. Objective 40 .
Figure 7. RIPLT  -HEV show increased luminal PNAd and HEC-6ST expression. RIPLT  (top panel) and RIPLT   (bottom panel) pancreatic
tissue sections were analyzed by two-color immunofluorescence analysis with MECA 79 (red) and anti-HEC-6ST (green) antibodies. The H&E stained
image was merged with MECA 79 staining to orient the histologic location of the vessels; objective 20 . RIPLT  infiltrates exhibited predominately
abluminal MECA 79  staining vessels and no detectable HEC-6ST expression similar to LT  /  MLN-HEV (Fig 6, bottom panel). In contrast, analysis
of RIPLT   pancreata revealed both luminal and abluminal MECA 79  vessels with coincident HEC-6ST expression on those luminal, pericellular
MECA 79  HEV. Bottom panel inset of RIPLT   HEV demonstrates intracellular HEC-6ST expression and cell surface PNAd expression–a pattern
more reminiscent of C57BL/6 PLN (Fig 6, top panel) than RIPLT  infiltrates. Objective 40 .T
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sion, and adhesion molecules between RIPLT  and RIPL-
T   mice provide insight into the selective requirements
for LT  and LT  in MLNs and PLNs. The differences in
the extent and location of PNAd expression in RIPLT  
mice when compared with RIPLT  mice correlated with
the expression of HEC-6ST, implicating LT   in the in-
duction of PNAd through its regulation of this important
enzyme. These studies emphasize that LT  is absolutely
critical by itself in its induction of MAdCAM-1, and in its
contribution to the LT   complex, as LT  alone had no
discernible effect on cellular accumulation or expression of
chemokines or adhesion molecules. However, LT   also
contributes a further element to cell recruitment, as demon-
strated by the 10-fold higher cell numbers in RIPLT  
pancreatic infiltrates compared with RIPLT  infiltrates.
Previous studies of Mebius et al. (2), demonstrating the
change in PLN HEV vascular addressins from predominant
MAdCAM-1 to PNAd, and the present data support a LT
driven kinetic developmental model of endothelial ad-
dressin expression on PLN-HEV. First, MAdCAM-1,
which is induced by LT 3 (33, 35), is expressed on HEV.
Second, abluminal PNAd is expressed. Third, luminal
PNAd is induced dependent on LT   and HEC-6ST ex-
pression. Thus, HEV of RIPLT  infiltrates resemble the
second stage of this model, whereas RIPLT   infiltrates
represent a later stage in HEV vascular addressin expression.
The role of the individual cytokines in regulation of other
molecules that contribute to PNAd expression, such as core
proteins CD34 and GlyCAM-1, modifying enzymes Fuc-
TIV and FucTVII and additional sulfotransferases, needs
further study.
The identity of the cell that responds to LT   is not ad-
dressed in the present studies, nor is it revealed whether
HEV respond directly or indirectly. The simplest scenario
is that an endothelial cell expresses the LT R and responds
to the membrane-associated cytokine; HEC-6ST is in-
duced and modifies the oligosaccharide side chain of the
core protein in the Golgi apparatus, giving rise to the
MECA 79 epitope. Alternatively, LT   may activate a
stromal cell or another intermediate LT R expressing cell
that induces HEC-6ST by means of additional factors.
Recently, it has been shown that LT R signaling in-
duces gene expression via two NF- B pathways (40, 41).
Signaling through the TNF receptors activates the classical
pathway resulting in nuclear translocation of p50:p65
heterodimers and expression of proinflammatory genes
(VCAM-1, MIP-1 , MIP-2). In addition to activation of
the canonical NF- B pathway, the LT R can also engage
the alternative pathway, which regulates NF- B–inducing
kinase (NIK) activity and subsequent p100 processing re-
sulting in nuclear translocation of RelB:p52 heterodimers
(40, 42). Both NIK and multiple alternative pathway target
genes such as CCL21, CCL19, and CXCL13 play crucial
roles in secondary lymphoid organogenesis (43, 44). It is
proposed that transcriptional activation of lymphoid che-
mokine genes and HEC-6ST observed in RIPLT   trans-
genic infiltrates could occur through the alternative NF- B
pathway.
The ratio of LT  to LT , presumably determining the
ratios of trimeric forms LT 3, LT 1 2, LT 2 1 and usage
of different signaling pathways, remains unknown at differ-
ent stages of development and in RIPLT   mice. A plau-
sible developmental hypothesis is that there is a progression
from LT 3 to the LT   complex. It is likely that there is a
mixture of LT 3, LT 2 1, and LT 1 2 in the RIPLT  
pancreas, explaining the continued high expression of
MAdCAM-1, along with PNAd and HEC-6ST. Such a
pattern may prevail in the MLN which coexpresses MAd-
CAM-1 and PNAd on the HEV. The ratio may be skewed
toward LT 1 2 in the adult PLN with expression of PNAd
and HEC-6ST, and little or no MAdCAM-1. In PP, there
may be a different ratio with a predominance of LT 3 and
LT 2 1 and a corresponding preponderance of MAd-
CAM-1 with abluminal PNAd.
Ectopic lymphoid accumulations have been termed ter-
tiary lymphoid organs to distinguish them from secondary
lymphoid organs (LN, PP, and spleen; reference 45). De-
velopment of these ectopic lymphoid accumulations has
been noted in the RIPLT  mouse (26, 27), the nonobese
diabetic (NOD) mouse (46, 47), and in human disease such
as rheumatoid arthritis (48–50) and thyroiditis (51). While
the initiating event in tertiary lymphoid organ develop-
ment in these human pathologies has not been elucidated,
the fact that similar lymphoid structures are induced by
transgenic expression of TNF/LT family members (26, 27)
or lymphoid chemokines (25–31) is intriguing. These stud-
ies have shown that multiple mechanisms can induce lym-
phoid accumulations. The present and other studies have
shown that LT 3 and the LT   complex induce chemo-
kines. Conversely, RIP driven expression of CXCL13 in-
duces expression of the LT   complex (29). Furthermore,
the expression of PNAd and MAdCAM-1 in RIPCCL21
infiltrates is reduced by treatment with an LT R-Ig (31).
Collectively, these studies reemphasize the parallels be-
tween chronic inflammation and lymphoid organ develop-
ment and suggest that lymphoid neogenesis mimics, at least
in part, the developmental program of secondary lymphoid
organs. The function of tertiary lymphoid organs was sug-
gested but not proven in our previous studies of RIPLT 
mice. The RIPLT   mice, with their high number of
L-selectin  cells, CD11c  cells, extensive FDC network and
prominent luminal PNAd expression, provide a superior
model to address this phenomenon.
Tertiary lymphoid organs could be either beneficial in
setting up a local site for antigen presentation or detrimen-
tal, leading to tissue injury and promoting epitope spreading
in autoimmune disease. In several aspects, the RIPLT 
mouse has the appearance of the early stages of Type I dia-
betes with a peri-islet leukocytic accumulation that does not
progress to an invasive insulitis or diabetes unless an addi-
tional signal is provided in the form of B7.1 coexpression
(52). The RIPLT   mouse appears to represent a later stage
of disease since the infiltrate invades the islet with clear evi-
dence of islet distortion. Nevertheless, some islet function
remains, indicating these animals have not progressed to in-
sulin-dependent disease. The precise signal that drives theT
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cells into the RIPLT   islets remains unknown, but could
be the intra-islet expression of CCL19. The provision of
putative antigen presenting cells (CD11c , CR1 ) and of
naive, L-selectin  cells, attracted by the luminal expression
of PNAd and CCL21 and CXCL13 may set the stage for
responsiveness to autoantigen leading to overt disease.
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